Mondrian Investment Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$174M Buy
346,262
+27,261
+9% +$13.1M 2.68% 12
2026
Q1
$157M Buy
319,001
+21,269
+7% +$11.5M 2.35% 15
2025
Q4
$173M Sell
297,732
-6,613
-2% -$3.74M 2.85% 11
2025
Q3
$148M Buy
+304,345
New +$142M 2.46% 12
2025
Q1
$107M Buy
214,506
+127,357
+146% +$69M 1.83% 29
2024
Q4
$52.1M Buy
+87,149
New +$47.9M 0.86% 44

Other funds holding TMO

Mondrian Investment Partners's TMO Position: Q2 2026 in Review

Mondrian Investment Partners increased its Thermo Fisher Scientific (TMO) stake by 8.5% in Q2 2026, buying an estimated $13.1M and bringing the position to 346,262 shares worth $174M. The position accounts for 2.68% of the portfolio, ranked #12.

Mondrian Investment Partners first reported a position in TMO in Q4 2024 and has held it in 6 quarters since. 2,623 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Mondrian Investment Partners held 346,262 shares of Thermo Fisher Scientific worth $174M as of Q2 2026.
  • Mondrian Investment Partners bought 27,261 Thermo Fisher Scientific shares in Q2 2026, an estimated $13.1M.
  • Thermo Fisher Scientific made up 2.68% of Mondrian Investment Partners's portfolio in Q2 2026, its #12 holding.
  • Mondrian Investment Partners first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 6 quarters since.
  • 2,623 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Mondrian Investment Partners's 13F filing for Q2 2026, filed 30 Jul 2026.